The Latest Breaking News from FDA

Ceruvia Lifesciences, a biopharmaceutical company, announced that it has produced the world's first LSD that meets stringent "Current Good Manufacturing Practices" (CGMP) standards required by the FDA for new drug approvals and is offering to supply it at no cost to qualified researchers. 

Cybin Inc. (CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics," has submitted an Investigational New Drug (or “IND”) application to the FDA.

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month, bringing the total for the year to 15. This compares to the 24 NMEs the Food and…

The U.S. and Canadian governments have traced recent outbreaks of hepatitis A infections to organic strawberries sold at major supermarket chains.

The U.S.

Plus: Libertarian Party changes abortion and bigotry planks, the FDA's weird rejection of fluvoxamine for treating COVID-19, and more...

The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of quality oncology…

The virus is likely to have spread due to contaminated organic strawberries sold between March 5 and April 25.

Other countries, including Canada and countries in the European Union, have already taken this potentially live-saving step to take a more addictive product off the market.

U.S. and Canadian regulators are investigating a hepatitis outbreak that may be linked to fresh organic strawberries

The FDA is investigating a hepatitis A outbreak potentially linked to strawberries sold at a number of retailers, including Trader Joe's, Kroger, Safeway, Aldi and Walmart.